Dingfeng Li, MD

Dr. Li is a staff physician at the Endocrinology and Metabolism Institute of the Cleveland Clinic Main Campus. After graduating with honors from Shanghai Jiao Tong University School of Medicine in 2014, he completed internal medicine residency at the John Stroger Hospital of Cook County in Chicago and was certified by the American Board of Internal Medicine in 2018. Concurrent to residency training, he obtained a Master of Science degree in Clinical Research at the Rush University. He then completed a three-year clinical and research fellowship in Endocrinology, Diabetes and Metabolism at the Mayo Clinic in Rochester, Minnesota, where he had an academic rank of Assistant Professor in Medicine. He joined the Cleveland Clinic after graduating from the fellowship in 2021. He currently holds an academic rank of Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.

Dr. Li has a strong clinical and research interest in pituitary and adrenal disorders. He has published multiple peer-reviewed manuscripts of original research and review in major endocrinology journals. He is an active member with several medical professional societies. He has been recognized by academic societies with various scholarship and travel awards.

Education & Professional Highlights

Appointed
2021

Education & Fellowships

Fellowship - Mayo Clinic Rochester, MN
Endocrinology, Diabetes and Metabolism
Rochester, MN USA
2021

Residency - John H. Stroger Jr. Hospital of Cook County
Internal Medicine
Chicago, IL USA
2018

Graduate School - RUSH UNIVERSITY
Clinical Research
CHICAGO, IL USA
2018

Internship - John H. Stroger Jr. Hospital of Cook County
Internal Medicine
Chicago, IL USA
2016

Medical Education - Shanghai Jiao Tong University School of Medicine
Clinical Medicine
Shanghai, China
2014

Certifications

Internal Medicine
Internal Medicine - Endocrinology, Diabetes and Metabolism

Specialty Interests

Pituitary and adrenal disorders

Awards & Honors

Outstanding Abstract Award - ENDO 2021, Endocrine Society 2021
Early Career Forum Travel Award - ENDO 2020, Endocrine Society 2020
Fellow’s Travel Award - ADA 79th Annual Scientific Sessions, American Diabetes Association 2019
Outstanding Graduate Award - Shanghai Jiao Tong University 2014
Merck-Serono China Elite Awards - Merck & Co. Inc. 2012
Top Grade Scholarship - Shanghai Jiao Tong University 2007, 2008, 2009
National Scholarship of China - Ministry of Education of the People's Republic of China 2007

Research & Publications

See publications for Dingfeng Li, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/18/2022, Dr. Li has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Primary Location

Cleveland Clinic Main Campus

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Part of Your Insurance?